News | News By Subject | News by Disease News By Date | Search News

Pancreatic Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AngioDynamics (ANGO) CEO Highlights First Year and Looks to the Future     5/4/2017
Momenta (MNTA) Halts Enrollment in Necuparanib Phase II Per Recommendation From the Independent Data Safety Monitoring Board     8/4/2016
Aduro Biotech (ADRO)'s Stock Craters After Pancreatic Cancer Drug Trial Misses Primary Endpoint     5/17/2016
NewLink Genetics (NLNK) Craters as Pancreatic Cancer Vaccine Fails Phase III Study, May Even Harm Patients     5/10/2016
Investors Hold Their Breath for Data from Aduro Biotech (ADRO), Novartis AG (NVS)     3/11/2016
Incyte (INCY) Stock Tumbles After Halting Another Jakafi Trial for Treating Solid Tumors     2/12/2016
Independent Experts Say Bay Area's OncoMed (OMED)'s Pancreatic Cancer Drug Unlikely to Succeed in Phase II Study     1/25/2016
RestorGenex (RESX) and Diffusion Pharma Merge to Form Wholly-Owned Oncology Subsidiary     12/28/2015
Threshold Pharma (THLD) Crumbles as Merck KGaA (MKGAF.PK) Abandons Cancer Drug After Trial Failures     12/7/2015
Former Biogen (BIIB) Exec Doug Williams to Head Startup Codiak BioSciences     11/18/2015
SoCal's Halozyme (HALO) To Expand With A Satellite Office In San Francisco     11/18/2015
Medivir (MVRBF) Terminates the ADAM8 Inhibitor Project for Pancreatic Cancer     11/17/2015
Momenta (MNTA) Puts a Temporary Hold on Enrollment in Phase II Necuparanib Study to Discuss Specific Toxicities     11/13/2015
Three Cancer Drugs are Up for FDA Approval in October     9/28/2015
OncoGenex (OGXI) Stock Plummets After Pancreatic Cancer Drug Misses Mark in Phase II Study     9/24/2015

News from Around the Web
Led by Former Eli Lilly (LLY) Exec, Apexian Out to Tackle Pancreatic Cancer     11/16/2016
Why Is Pancreatic Cancer So Hard To Kill?     10/4/2016
Oral Bacteria May Help Spot Pancreatic Cancer, New York University Study     4/20/2016
Engineering T Cells To Treat Pancreatic Cancer, Fred Hutchinson Cancer Research Center Study     4/19/2016
Implantable Device Targets Pancreatic Cancer, MIT Study     4/18/2016
Magnesium May Lower Pancreatic Cancer Risk, Indiana University Researchers Find     1/4/2016
New Test May Improve Diagnosis And Treatment Of Pancreatobiliary And Other Gastrointestinal Cancers, University of Chicago Study     11/24/2015
3-D Pancreatic Cancer Organoid May Help Predict Clinical Responses, Nature Medicine Publishes     10/28/2015
Early Stage Pancreatic Cancer Urine Test Possible After Biomarker Discovery, Queen Mary University Of London Study     8/3/2015
Tiny Particles In Blood Useful For Early Diagnosis Of Pancreatic Cancer, University of Texas MD Anderson Cancer Center Study     6/25/2015
Wild Berry Extract May Boost Effect Of Pancreatic Cancer Drug, University of Southampton Study     9/23/2014
Chinese Herbal Extract May Help Kill Off Pancreatic Cancer Cells, American Physiological Society Reveals     7/3/2014
Low-Dose Aspirin Slashes Pancreatic Cancer Risk In Half, Yale University Study     6/30/2014
How Green Tea Upsets Cancer Cell Metabolism, Los Angeles Biomedical Research Institute Study     6/4/2014
Gene Mutation Found for Aggressive Form Of Pancreatic Cancer, University of California, San Diego (UCSD) Study     5/30/2014

Press Releases
Halozyme (HALO) Phase II Data In Advanced Pancreas Cancer Presented At European Society For Medical Oncology Symposium     6/28/2017
Avant Diagnostics Announces Confirmatory Clinical Utility Data For Theralink In Pancreatic Cancer     6/27/2017
FibroGen (FGEN) Granted Orphan Drug Designation For Pamrevlumab In The Treatment Of Pancreatic Cancer     6/22/2017
Moleculin Biotech (MBRX) Announces Significant Discovery With Potential To Treat Pancreatic Cancer     6/21/2017
Intezyne Technologies LLC Granted Orphan Drug Designation For IT-139 In Pancreatic Cancer     6/20/2017
Codiak BioSciences Release: Potential Therapeutic Use Of Exosomes Reported In Nature     6/8/2017
Sun BioPharma Announces Completion Of The Fifth Patient Cohort In The Dose Escalation Phase Ia Study Of SBP-101 For Pancreatic Cancer     6/7/2017
Celldex (CLDX) Presents Phase I Study Of Varlilumab And Opdivo At 2017 ASCO Annual Meeting     6/6/2017
Targovax Presents Further Positive Clinical Data From TG01 Phase I/II Trial At 2017 ASCO Annual Meeting     6/6/2017
Halozyme (HALO) Phase II Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO     6/5/2017
MabVax Therapeutics Phase I Trial Results Of Antibody Therapy MVT-5873 For The Treatment Of Advanced Pancreatic Cancer Presented At The 2017 ASCO Annual Meeting     6/5/2017
ARMO BioSciences Announces Encouraging Survival Data Observed In Patients With Advanced Pancreatic Cancer In Phase I/Ib Trial Of Immunotherapy AM0010     6/5/2017
MabVax Therapeutics Signs Research Agreement With Memorial Sloan-Kettering Cancer Center To Develop Novel CAR T-Cell Based Anti-Cancer Immunotherapies For Treatment Of Pancreatic And Small Cell Lung Cancers     5/31/2017
The Lustgarten Foundation for Pancreatic Cancer Research Release: FDA Approves Pembrolizumab for Pancreatic Cancers With Mismatch Repair Deficiency     5/24/2017
CivaTech Oncology, Inc. Offers New Technology To Fight Pancreatic Cancer     5/23/2017